Table 1. Metastasis data and measured iodine concentrations.

Patient #	Tumor primary type	Tumor volume (cm3)	Tumor mean radius (cm)	Mean iodine concentration in tumor volume (mg/mL)	Maximum iodine concentration in tumor (mg/mL)
1	Lung well-differentiated adenocarcinoma	14.1	1.5	2.14±0.45	3.04±1.12
2	Dorsal skin malignant melanoma	11.17	1.39	1.76±0.36	2.36±0.85
3	Lung right superior lobe undifferentiated large cells carcinoma	1.58	0.72	2.17±0.37	3.28±0.87
4	Lung right superior lobe undifferentiated large cells carcinoma	2.43	0.84	0.74±0.30	0.93±0.67
5	Lung right superior lobe squamous cells carcinoma	13.63	1.48	1.32±0.34	1.25±0.69
5′	Lung right superior lobe squamous cells carcinoma	8.84	1.28	1.10±0.43	1.19±1.07
6	Bladder urothelial carcinoma with large cells and giant sarcomatoid cells	6.74	1.17	1.14±0.33	1.59±0.59
6′	Bladder urothelial carcinoma with large cells and giant sarcomatoid cells	3.71	0.96	1.64±0.35	2.07±0.49
7	Lung superior right lobe adenocarcinoma, TTF-1	8.66	1.27	2.43±0.45	2.89±1.12
7′	Lung superior right lobe adenocarcinoma, TTF-1	0.58	0.52	1.14±0.53	2.73±0.64
8	Breast invasive duct differentiated carcinoma	43.51	2.18	2.82±0.58	3.67±0.94
9	Lung superior right lobe poorly differentiated with large cells carcinoma	10.46	1.36	3.57±0.50	4.15±1.31
10	Lung middle right lobe adenocarcinoma	4.17	1	1.34±0.54	2.10±1.21
11	Cervical skin malignant melanoma	1.45	0.7	2.84±0.56	3.42±1.33
11′	Cervical skin malignant melanoma	0.56	0.51	1.99±0.52	2.45±1.12
12	Renal	4.37	1.01	2.82±0.70	4.28±1.11
	Mean±s.d.	8.5	1.12	1.94±0.12	2.59±0.25

TTF-1, thyroid transcription factor 1. Summary of primary tumor characteristics and iodine concentrations (average and maximum) reached in the whole volume of metastasis for all recruited patients. The prime symbol is used when a patient has two metastasis in the studied field of view.